Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Constellation Pharmaceuticals Inc (CNST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 307,091
  • Shares Outstanding, K 25,806
  • Annual Sales, $ 0 K
  • Annual Income, $ -59,930 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.80
  • Number of Estimates 5
  • High Estimate -0.79
  • Low Estimate -0.81
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.79 +21.55%
on 03/19/19
14.04 -15.24%
on 03/28/19
+1.90 (+19.00%)
since 03/18/19
3-Month
5.90 +101.69%
on 01/22/19
14.04 -15.24%
on 03/28/19
+5.58 (+88.29%)
since 01/18/19

Most Recent Stories

More News
Constellation Pharmaceuticals to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar...

CNST : 11.90 (unch)
Report: Exploring Fundamental Drivers Behind The Cooper Companies, Encompass Health, SilverCrest Metals, Constellation Pharmaceuticals, Leaf Group, and TESSCO Technologies -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of The Cooper Companies, Inc. (NYSE:COO),...

SVCMF : 2.2600 (+1.80%)
EHC : 61.27 (+6.17%)
COO : 281.22 (+0.69%)
CNST : 11.90 (unch)
LFGR : 11.15 (-0.89%)
SILV : 3.40 (+6.92%)
TESS : 19.58 (+0.05%)
LEAF : 8.73 (-3.54%)
Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting

-- Clinical activity of CPI-1205 was seen in subsets of advanced metastatic castration-resistant prostate cancer (mCRPC) patients

CNST : 11.90 (unch)
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2018 Financial Results

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced its fourth-quarter...

CNST : 11.90 (unch)
Constellation Pharmaceuticals to Present at Upcoming Investor Conference

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar...

CNST : 11.90 (unch)
Constellation Pharmaceuticals Appoints Jessica Christo as Chief Product Development Officer

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jessica...

CNST : 11.90 (unch)
What's in Store for Universal Health (UHS) Q4 Earnings?

Universal Health's (UHS) earnings in the fourth quarter are likely to gain from higher admissions and patient days.

FOLD : 12.69 (-1.40%)
UHS : 124.51 (+1.51%)
CNST : 11.90 (unch)
ADRO : 3.38 (-0.88%)
Constellation Pharmaceuticals Announces Appointment to Board of Directors

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Scott...

ESPR : 40.94 (+2.09%)
CNST : 11.90 (unch)
Molina Healthcare (MOH) Q4 Earnings & Revenues Top Estimates

Molina Healthcare's (MOH) fourth-quarter earnings trump estimates on the back of lower costs and higher premium revenues.

CNST : 11.90 (unch)
ALDR : 12.68 (-0.78%)
MOH : 120.68 (+3.44%)
THC : 23.41 (+2.00%)
Ensign Group's (ENSG) Q4 Earnings Top Estimates, Surge Y/Y

Ensign Group's (ENSG) fourth-quarter earnings rise on the back of solid segmental growth.

CNST : 11.90 (unch)
ALDR : 12.68 (-0.78%)
ENSG : 48.25 (+1.47%)
THC : 23.41 (+2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade CNST with:

Business Summary

Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company's lead product candidates consists of CPI-1205, which inhibits enhancer of zeste homolog 2 and...

See More

Key Turning Points

2nd Resistance Point 12.77
1st Resistance Point 12.33
Last Price 11.90
1st Support Level 11.24
2nd Support Level 10.59

See More

52-Week High 14.04
Last Price 11.90
Fibonacci 61.8% 10.21
Fibonacci 50% 9.02
Fibonacci 38.2% 7.84
52-Week Low 4.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar